Abivax (NASDAQ:ABVX) Earns Buy Rating from Analysts at Jefferies Financial Group
Jefferies Financial Group initiated coverage on shares of Abivax (NASDAQ:ABVX – Free Report) in a research note published on Monday morning, MarketBeat reports. The firm issued a buy rating and a $160.00 price target on the stock. Other analysts have also issued research reports about the company. Guggenheim reissued a “buy” rating and set a […]
19 Mar 01:50 · The Cerbat Gem